Note: Descriptions are shown in the official language in which they were submitted.
SELF-SEALING DRESSING
[0001] The present
application claims benefit of the filing
date of U.S. Provisional Patent Application No. 61/420,997,
filed December 8, 2010, entitled "Self-Sealing Dressing".
BACKGROUND OF THE INVENTION
[0002] Existing
dressings for reduced pressure therapy or
negative pressure wound therapy (NPWT) often can be overly stiff
and the pressure sensitive adhesives used to maintain them
during use can be prone to leak formation. Thus, it is
relatively easy to form leaks between a sealant film of the
dressing and the patient's skin, across the border of these
films. The
formation of a leak usually results in an alarm
condition that must be reset by an attending nurse or caregiver.
Attending to the leaks that arise during NPWT can consume
appreciable resources and decrease caregiver efficiency. In
addition, leaks can result in reduced efficacy of treatment for
the patient.
[0003] In the
treatment of some wounds, especially those
covering pressure bearing areas, such as the feet and sacral
region, and those near high use regions of the body, such as
hands, dressings can be prone to curling up during use. This
is often referred to as rucking. Rucking can lead to catching
of the dressing on adjacent objects, loss of seal and/or exposure
of the wound site to the surroundings. Generally, the highly
aggressive adhesives currently used in reduced pressure therapy
may be particularly prone to this phenomenon, as exposed
adhesives are more likely to catch on adjacent surfaces.
[0004]
Furthermore, highly aggressive adhesives can be
painful to remove, especially around sensitive areas of the
body. Less aggressive adhesives, however, typically have not
fared well in terms of maintaining adhesion for a wide segment
of the patient population during patient activity, and in a
range of climates commonly experienced in clinical settings.
-1-
CA 2819462 2018-04-26
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
[0005] As the miniaturization trend for NPWT devices
continues, successful miniaturization may depend, in part, on the
integrity of the seal around the wound provided by the dressing.
In addition, the electrical power requirements needed to maintain
a vacuum at a wound site covered by a dressing in the presence of
a leak can be dramatically higher than that needed to maintain a
vacuum in a low or zero leakage condition.
[0006] Further,
moist wound healing generally needs a dressing
with a relatively moderate moisture vapor transfer rate (MVTR).
A typical rate for eliciting a moist wound healing environment is
less than 35g/m2/hr, with risk of maceration occurring for values
less than about 8g/m2/hr. Yet, in the peripheral tissues such as
the hands or feet, there is a need for a relatively high MVTR,
such as 50-90 g/m2/hr, to minimize moisture storage at the tissue
interface, which can lead to unwanted maceration. In addition,
it is generally accepted that to maintain a vacuum with minimal
effort, a dressing should have an MVTR that is generally as low
as possible. Further
complicating the situation, patients may
perspire at different rates, with such rates fluctuating
throughout the day due to changes in the local environment, the
patient's degree of activity, clothing, etc. These
competing
goals for MVTR of a dressing along with the uncertainty of wound
exudate liberation and perspiration further complicate the design
of a suitable dressing.
[0007]
Particular to applications in NPWT, the oxygen transfer
rate (OTR) of the adhesive film of a dressing may affect the
power required to maintain a vacuum on the wound site. Thus a
combination of MVTR and OTR may need to be considered to improve
the design of a dressing for such applications.
[0008]
Therefore, there exists a need for a dressing that
provides improved wound healing for NPWT, avoids leak formation
between the dressing and the patient, avoids edge lifting,
rolling or rucking of the dressing during use, avoids causing
pain to a patient during a change of the dressing and minimizes
the power needed to maintain a vacuum at a wound site to which
the dressing is applied.
-2-
BRIEF SUMMARY OF THE INVENTION
[0009] In
accordance with aspects of the invention, a dressing
for application to skin of a human may include a substrate
including elastomeric material, and a cold flow adhesive layer
coupled to the substrate. The adhesive layer may be adapted to
adhere to skin of a human to form a substantially gas impermeable
seal between the adhesive layer and the skin that is maintained
during at least one of repeated flexure or extension of the
dressing. A maximum
thickness of the combination of the
substrate and the adhesive layer may be about 25 pm.
[0009a] In
accordance with another aspect of the invention there
is provided a dressing adapted for negative pressure wound therapy
comprising: a substrate having a top surface and a rear surface,
the substrate including an elastomeric material; and a cold flow
adhesive layer disposed over at least a portion of the rear surface
of the substrate, wherein a maximum thickness of the combination
of the substrate and the cold flow adhesive layer is about 25 pm;
and an opening extending through an entirety of the thickness of
the substrate.
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] FIG. 1 is
a perspective view of a self-sealing
dressing, in accordance with an aspect of the invention.
[0011] FIG. 2 is
a cross-sectional view of the dressing of
FIG. I taken along line 2-2.
[0012] FIG. 3 is
a diagrammatic view of a wound site to which
an exemplary embodiment of a self-sealing dressing is applied, in
accordance with an aspect of the present invention.
[0013] FIG. 4 is
a diagrammatic view of a sacral wound site to
which an exemplary embodiment of a self-sealing dressing is
applied, in accordance with an aspect of the present invention.
DETAILED DESCRIPTION
[0014] A self-
sealing dressing 10 in accordance with aspects
of the present invention is shown in FIGs. 1 and 2. The dressing
-3-
CA 2819462 2019-07-03
may be in the form of a laminate including a substrate 12
having a top surface 14 and a rear surface 16, and an adhesive
layer 18 disposed over a portion of the rear surface of the
substrate. The substrate may be a thin polyurethane film and
include an elastomer or a thermoplastic elastomer.
[0015] As used in
this disclosure, terms such as "top",
"front", "bottom" and "rear" refer to a frame of reference in
which the dressing is applied to a , wound site with the rear
surface 16 of the substrate facing the wound site. In an applied
state of the dressing, the rear surface of the substrate
confronts the wound site and the top surface of the substrate
-3a-
CA 2819462 2019-07-03
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
faces in a direction away and generally opposite to the wound
site.
[0016] The
adhesive layer may include cold flowing, shear
thinning silicone gel adhesive which is patterned along a
selected portion or portions of the rear surface 16 of the
substrate, such as adjacent to exposed outer edge surfaces 20 of
the substrate extending between the top and rear surfaces of the
substrate. The
adhesive desirably may be formed from
biocompatible material and include materials selected so as not
to sensitize tissue.
[0017] As used
in this disclosure, a statement that a surface
of a structure of the dressing is "exposed" indicates that the
structure is in contact or communication with an environment
external to the dressing.
[0018] The
adhesive layer may be applied on the substrate to
have a dry thickness of less than about 50 pm, 25 pm, 10 pm or 5
pm. Generally, for a given composition, the thicker the layer of
adhesive, the higher the adhesion strength that can be achieved
between the adhesive layer and another surface. In the dressing
10, an adhesive layer having a relatively small thickness may be
beneficial for reducing rucking during use.
[0019] In one
embodiment, the substrate of the dressing may
have a thickness of about 1.2-1.9 times greater than the
thickness of the adhesive layer. In
another embodiment, the
substrate and adhesive layer of the dressing may have a combined
thickness of at least about 8 pm.
[0020] The
dressing 10 may include a lubricious layer 22
disposed over the top surface 14 of the substrate 12. The
lubricious layer may include materials to render the exposed top
surface of the dressing lubricous, decrease the surface energy at
the exposed top surface of the dressing, render the exposed top
surface of the dressing hydrophobic, and/or decrease the
coefficient of friction at the exposed top surface of the
dressing.
[0021] The
dressing 10 also may include a release film layer
24 disposed on a rear surface 26 of the adhesive layer 18 and
-4-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
extending over the rear surface 16 of the substrate. In one
embodiment, the release film layer 24 may be disposed along the
perimeter of the dressing, only upon the rear surface of the
adhesive layer. The
release film layer 24 may maintain the
adhesive layer in a desired condition during storage and
shipping, to prevent flow of the adhesive during shipment and
storage. When the dressing is to be applied to a wound site, the
dressing may be released from the release layer 24 and placed
onto the wound site before significant cold flow of the adhesive
gel of the adhesive layer may occur.
[0022] The
dressing 10 may further include an opening or
perforated region 30 extending through the entirety of the
thickness of the substrate and which is exposed at the top and
rear surfaces of the substrate. A channel or tube fitting 32 may
be mounted at the top surface of the substrate to surround the
opening 30, using a layer of adhesive 34. The adhesive 34 may be
a standard pressure sensitive adhesive. In an
alternative
embodiment, the adhesive may be a cold flowing silicone gel
adhesive, such that self-sealing may occur if the seal is
disturbed by patient movement and leaks may be prevented at the
point where the suction line is attached to the dressing.
[0023] In
addition, a foam filled element 36 may be mounted at
the top surface of the substrate to surround the channel fitting
32, also using the adhesive layer 34. The foam filled element 36
may be close celled polyurethane foam to minimize leakage while
providing a cushioning effect between the wound and the channel
fitting.
[0024] In an
exemplary application of the dressing 10, the
dressing 10 may be used to cover a wound site of a patient, such
as a portion of a human hand 40 at which a finger has been
severed as shown in FIG. 3. The tube fitting 32 may be attached
to an end of a drain tube 50, so as to permit the tube 50 to
convey fluids or other materials from the wound site that may be
drawn from the wound site, through the opening 30 in the dressing
and into the drain tube, such as by application of a vacuum to
the end of the drain tube remote from the end attached to the
-5-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
tube fitting 32. With the drain tube attached to the dressing,
the release film 24 may be removed and then the dressing may be
moved over the region of the hand 40, so the outer perimeter or
border of the dressing generally surrounds the severed finger.
The dressing 10 may then be moved toward the skin of the patient
to cause the adhesive layer to contact and form a seal with the
skin, and desirably enclose the wound site.
[0025] In one
embodiment, the substrate of the dressing
desirably may be substantially gas impermeable, so as to provide
for efficient maintenance of a pressure differential between the
region enclosed by the substrate and adhesive layer and the
environment exterior to the enclosed region.
[0026]
Advantageously, the dressing 10 may be formed from
materials that provide that the dressing is soft and conforming
to the configuration of the wound site, such as the hand in the
vicinity of the severed finger wound site, to provide a self-
healing (self-sealing) adhesive interface at the adhesive layer.
The cold flowing adhesive layer of the dressing may create a
border seal for the dressing, to provide that the dressing may be
self-healing with respect to the formation of leaks. For
example, referring to FIG. 4, if the applied dressing 10 forms a
leak along the adhesive border at a sacral wound site, at which
movement is likely and which has a generally non-planar surface,
based on formation of a wrinkle in the dressing when the patient
moves, the leak may self-seal at the adhesive border under
continued suction applied from a pump through the drain tube to
the dressing 10.
[0027] In a
desired embodiment, the dressing may be less than
about 25 pm in thickness, and a seal between the dressing and the
wound site may be maintained during repeated flexure and/or
extension of the dressing, and if a leak is formed in the seal,
the dressing may self-seal at the leak by application of suction.
This self-sealing capability of the inventive dressing is in
contrast to dressings of the prior art, which do not provide for
self-sealing upon application of suction at the dressing, thereby
compromising therapy and warranting action by an attending nurse.
-6-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
[0028] In one
embodiment, upon application of a vacuum at a
wound site to which the dressing is applied, the dressing may
permanently deform, resulting in minimal stresses being applied
to the bond line between the dressing and the wound site.
[0029] In one
embodiment, the substrate of the dressing may be
sufficiently elastic, such as having an elasticity of about 10
N/mm2 or an elasticity of about 5, 2 or 1 N/mm2, to prevent undue
stress along the seal formed by the adhesive layer of the
dressing, during repeated flexure and extension of the dressing,
such as may be caused by movement of the skin, stretching around
the skin or flexure of the skin at the wound site.
[0030] In one embodiment, the adhesive layer may have
sufficiently high peel strength, such that the adhesive layer,
following application to form a seal to tissues at a wound site,
does not become at least partially unadhered to the tissues
during use. In one
embodiment, the adhesive layer may be
provided on the dressing so that the peel strength of the
dressing is about 0.1-5 N/in, about 0.5-3 N/in or about 1-2 N/in.
[0031] In a
further embodiment, the adhesive layer may be
hydrophobic, such as a hydrocolloid adhesive, and maintain
adhesive strength, even in the presence of moisture, so as to
resist ingress of moisture.
[0032] In a
further embodiment, referring again to FIG. 2, the
substrate 12 of the dressing 10 may be sufficiently microtextured
and porous at the rear surface 16, such that the cold flow
adhesive of the adhesive layer 18 may become intimately
integrated with the substrate 12 during fabrication of the
dressing to form an integrated layer region 70 at the rear
surface 16 adjacent the adhesive layer 18. The integrated region
70 may provide that, when the dressing which is bonded to tissue
at the wound site by the adhesive layer is removed from the wound
site, the adhesive layer 18 may remain a part of the dressing
laminate and not remain on the tissue when the dressing is
removed from the wound site.
-7-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
[0033] In a
further embodiment, the substrate of the dressing
may be a plastically deforming film, such as a cling wrap or
polyethylene film, or stomahesive composition.
[0034] In an
alternative embodiment, the substrate of the
dressing may have a pseudo elastic stretchable region. The
pseudo elastic stretchable region may have a pseudo elastic
stretch characteristic that is maintained at linear strains of up
to about 80%, up to about 40% or up to about 20%. In one
embodiment, when the dressing is stretched beyond, for example,
20% stretch, the substrate of the dressing may behave pseudo
elastically and not undergo significant permanent deformation.
Thus, during use, the dressing may contort to accommodate
movement, stretching, fluids and the like, but upon removal, the
dressing may be sufficiently resilient to avoid tearing.
[0035] In
another embodiment, the dressing may be easily
removed by applying a warm compress near to or over the regions
of the laminate with the adhesive, before pulling on the dressing
to remove the dressing from the wound site.
[0036] In an
exemplary method of fabrication of the inventive
dressing, a substrate 12 may be provided with an opening 30
extending through the entirety of its thickness. The
opening
desirably has a width or diameter of about 20 mm or 40 mm. A
layer of cold flowing adhesive 18 may be selectively deposited on
the rear surface of the substrate, such as along the entirety of
the perimeter of the rear surface. A release film may be applied
over the adhesive layer 18, and optionally extend over the rear
surface of the substrate. A layer of adhesive 34 may be applied
at a portion of the top surface of the substrate surrounding the
exposed portion of the opening, and a tube fitting 32 may be
placed on the adhesive. The
adhesive 34 may then be cured to
attach the tube fitting to the substrate. Then,
additional
adhesive 34 may be applied at a portion of the top surface of the
substrate surrounding the tube fitting, and a foam filled
element, which is configured to surround the tube fitting, may be
placed on the adhesive. The
additional adhesive may then be
cured to attach the foam filled element to the substrate. A
-8-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
lubricious coating layer may be deposited on the portions of the
top surface of the substrate that are not covered by the tube
fitting and the foamed element.
[0037] Exemplary
self-sealing dressings that may be fabricated
in accordance with the present invention are described below.
[0038] 1) In one
example, cold flow adhesive material may be
coated onto a 25 pm thick polyurethane film, such that the
resulting dry adhesive film has a thickness of 7 um. For this
dressing, it was found that the adhesive is reasonably aggressive
to the skin, and the film is relatively durable in the presence
of acetone and has exceptionally low rucking effects.
[0039] 2) In
another example, a cold flow adhesive material
may be coated onto a 12 pm thick polyurethane film. The
resulting dry adhesive of the dressing had a thickness of 7 pm.
For this dressing, it was found that the adhesive is reasonably
aggressive to the skin, and the film is relatively durable in the
presence of acetone. In addition, the film has exceptionally low
rucking effects.
Furthermore, the dressing showed visibly
superior conformance to microcracks on the surface of the skin
relative to the dressing of Example 1.
[0040] 3) In
another example, cold flow adhesive material may
be coated onto an 8 pm thick thermoplastic elastomer film having
a shore hardness of about 30A and an elongation to failure of
about 800%. The
resulting dry adhesive of the dressing had a
thickness of about V pm. It was
found that the adhesive is
reasonably aggressive to the skin, and the film is relatively
durable in the presence of acetone. The film
also showed
excellent rucking resistance.
Furthermore, the film showed
nearly ideal conformance to microcracks on the surface of the
skin. In addition, the film conformed very well to the skin in
regions where sufficient and repeated movement occurred during
use.
[0041] The
performance of the inventive self-sealing dressings
was compared with prior art dressings with respect to MVTR, by
performing examinations including a vacuum test on a concave
feature; a rucking test, which included a test where the films
-9-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
are stroked with a brush for a predetermined number of strokes
and the distance that the edge rolled up is measured; a comfort
determination; and a clarity determination.
[0042] 1) A
prior art dressing ("Dressing 1") about 50 pm
thick and including an adhesive was examined. The adhesive was
estimated to be about 25 pm thick and appeared to be acrylic, and
the substrate appeared to be low grade polyurethane. The
following was observed. The
Dressing 1 was reasonably elastic
and the adhesive was very aggressive. The
Dressing 1 was
exceedingly painful to remove from skin with hair. The
entire
Dressing 1 dissolved very quickly in acetone. The Dressing 1 was
sufficiently stiff so as to interfere with movement around
joints. The Dressing 1 was also sufficiently stiff such that it
could not easily be applied to convex surface features. In
addition, the Dressing 1 was very prone to rucking and its use
was painful as hairs at the wound site would get pulled into the
roll during rucking.
[0043] 2) A prior
art dressing ("Dressing 2") about 50 pm
thick was examined. Upon
removal of the adhesive from the
Dressing 2, the substrate was measured to be 25 pm thick. The
Dressing 2 felt a little stiffer than Dressing 1 although it was
reasonably elastic. It was
observed that the Dressing 2
dissolved quickly in acetone with the adhesive dissolving much
more quickly than the substrate, such that it was believed that
the adhesive was an acrylate pressure sensitive adhesive and the
substrate was a low grade polyurethane. The
Dressing 2 was
sufficiently stiff so as to Interfere with movement around joints
of a patient when applied to a wound site at the joints of a
patient. Dressing
2 was also sufficiently stiff such that
Dressing 2 could not easily be applied to a wound site having
convex surface features. In
addition, the Dressing 2 was very
prone to rucking, and the removal process was painful as hairs of
a patient would get pulled into the roll during rucking.
Overall, Dressing 2 behaved very similarly to the Dressing 1
except that it felt stiffer.
-10-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
[0 0 4 4] 3) A prior
art dressing ("Dressing 3") about 90 pm
thick was examined. The
adhesive portion was about 35-40 pm
thick, and the substrate was about 50 pm thick. It was
found
that the Dressing 3 was not very elastic, and it could not be
readily repositioned. In other words, after application to skin
at a wound site, when the Dressing 3 was broken away from the
skin, the Dressing 3 could not be re-adhered to the skin. The
entire Dressing 3 quickly dissolved in acetone. The
adhesive
appeared to be an acrylic pressure sensitive adhesive, and the
substrate appeared to be a low grade polyurethane film. In
addition, the adhesive was painfully aggressive and tore out hair
upon removal of the Dressing 3 from the wound site. The Dressing
3 was sufficiently stiff so as to interfere with movement around
joints. The Dressing 3 was also sufficiently stiff, such that it
could not easily be applied to convex surface features. In
addition, the Dressing 3 was very prone to rucking and pulled
hairs into the roll during rucking, which contributed to the pain
experienced during the removal process.
[0045] 4) A
prior art dressing ("Dressing 4") applied to a
difficultly sized wound, for example, a sacral wound site, was
examined. It was found that a leak formed along the edge of the
Dressing 4, which apparently caused failure of the overall seal
of the dressing.
[0046] Thus, the
inventive dressing provides for improved
performance over prior art dressings. In
particular, the
characteristics of the adhesive of the inventive dressing, such
as the complex modulus, may have a higher mechanical loss factor
than that of an acrylate pressure sensitive adhesive used in
prior art dressings over typical usage temperatures and time
frames. In
addition, a leak formed along the edge of the
inventive dressing applied to a wound site may self-seal under
continued suction. Further, advantageously, the dressing of the
present invention may avoid exposed portions, such as exposed
edges of the substrate, catching on external objects; may provide
that the edge portions of the dressing may be repositioned with
relative ease if they are pulled up from the wound site; may
-11-
CA 02819462 2013-05-30
WO 2012/078707 PCT/US2011/063648
provide that the adhesive is aggressive while simultaneously
allowing ease of and relatively low pain removal; may
substantially conform to wrinkles and cracks in the skin; may
have sufficient elasticity, such that the dressing interface is
not easily stressed during wear; and may remain conformed to the
wound site in high movement areas of the body, such as over
knuckles.
[0047] Although
the invention herein has been described with
reference to particular embodiments, it is to be understood that
these embodiments are merely illustrative of the principles and
applications of the present invention. It is
therefore to be
understood that numerous modifications may be made to the
illustrative embodiments and that other arrangements may be
devised without departing from the spirit and scope of the
present invention as defined by the appended claims.
-12-
